Excessive daytime sleepiness in de novo and treated Parkinson's disease

Movement Disorders

Volumn 17, Issue 5, 2002, Pages 1026-1030

  Fabbrini, Giovanni ^a   Barbanti, Piero ^a   Aurilia, Cinzia ^a   Vanacore, Nicola ^a   Pauletti, Caterina ^a   Meco, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Excessive daytime sleepiness; Parkinson's disease; Sleep

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; LISURIDE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE;

ADULT; AGED; ARTICLE; COFFEE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SLEEP PARAMETERS; SOMNOLENCE; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036764841     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10193     Document Type: Article

References (29)

1. Poewe W, Hogl B. Parkinson's disease and sleep. Curr Opin Neurol 2000;13:423-426.
2. Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999;52:1908-1910.
3. Reyner LA, Horne JA. Falling asleep whilst driving: are drivers aware of prior sleepiness? Int J Legal Med 1998;111:120-123.
4. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-545.
5. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990;5:280-285.
6. Aldrich MS. Parkinsonism. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 2nd ed. Philadelphia: WB Saunders; 1994. p 783-789.
7. Rye DB, Bliwise DL, Dihenia B, Gurecki P. FAST TRACK: daytime sleepiness in Parkinson's disease. J Sleep Res 2000;9:63-69.
8. Pal PK, Calne S, Samii A, Fleming JAE. A review of normal sleep and its disturbances in Parkinson's disease. Parkinsonism Relat Disord 1999;5:1-17.
9. Kales A, Ansel RD, Markham CH, Scahrf MB, Tan TL. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 1971;12: 397-406.
10. Bergonzi P, Chiurulla C, Gambi D, Mennuni G, Pinto F. L-dopa plus dopa-decarboxylase inhibito. Sleep organization in Parkinson's syndrome before and after treatment. Acta Neurol Belg 1975; 75:5-10.
11. Nausieda PA, Weiner WJ, Kaplan LR, Weber S, Klawans HL. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol 1982;5:183-194.
12. Parkinson Study Group. Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. JAMA 1997;278:125-130.
13. Sethi KD, O'Brien CF, Hammerstad JP, Adler CH, Davis TL, Taylor RL, Sanchez-Ramos J, Bertoni JM, Hauser RA. Ropinirole for the treatment of early Parkinson's disease. Arch Neurol 1998; 55:1211-1216.
14. Olanow CW, Fahn S, Muenter M, et al. A multicenter, double-blind, placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Mov Disord 1994;9:40-47.
15. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992:42;1142-1146.
16. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
17. Buysse DJ, Reynolds CF III, Monk TH, Hoch CC, Yeager AL, Kupfer DJ. Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI). Sleep 1991;14:331-338.
18. van Hilten JJ, Weggeman M, van der Velde EA, Kerkhof GA, van Dijk JG, Roos RA. Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1993;5:235-244.
19. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 1999;14:922-927.
20. Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988;11:512-519.
21. Lemke MR, Puhl P, Broderick A. Motor activity and perception of sleep in depressed patients. J Psychiatr Res 1999;33:215-224.
22. King AC, Oman RF, Brassington GS, Bliwise DL, Haskell WL. Moderate-intensity exercise and self-rated quality of sleep in older adults. A randomized clinical trial. JAMA 1997;277:32-37.
23. Elsenbruch S, Harnish MJ, Orr WC. Subjective and objective sleep quality in irritable bowel syndrome. Am J Gastroenterol 1999;94: 2447-2552.
24. Zeitlhofer J, Schmeiser-Rieder A, Tribl G, Rosenberger A, Bolitschek J, Kapfhammer G, Saletu B, Katschnig H, Holzinger B, Popovic R, Kunze M. Sleep and quality of life in the Austrian population. Acta Neurol Scand 2000;102:249-257.
25. Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001;16: 507-510.
26. Olanow CW, Schapira AH, Roth T. Waking up to sleep episodes in Parkinson's disease. Mov Disord 2000;15:212-215.
27. Ferreira JJ, Galitzky M, Montastruc JL, Rascol O. Sleep attacks and Parkinson's disease treatment. Lancet 2000;355:1333-1334.
28. Pal S, Bhattacharya KF, Agapito C, Chaudhuri KR. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm 2001;108:71-77.
29. Pal S, Lomax C, Pezzella FR, Forbes A, Chaudhuri KR. The validity of a novel scale for assessing nocturnal sleep disturbances in Parkinson's disease: the Parkinson's disease sleep scale [abstract]. Parkinsonism Relat Disord 2001;7(Suppl.):50-51.